Enliven Therapeutics (ELVN) Return on Capital Employed (QoQ) (2020 - 2026)
Enliven Therapeutics (ELVN) Return on Capital Employed (QoQ) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Enliven Therapeutics | 3.22 Bn | 3.22 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 40.00 |
| Dec 31, 2025 | -237.00 |
| Sep 30, 2025 | 619.00 |
| Jun 30, 2025 | 729.00 |
| Mar 31, 2025 | -184.00 |
| Dec 31, 2024 | -134.00 |
| Sep 30, 2024 | -236.00 |
| Jun 30, 2024 | 179.00 |
| Mar 31, 2024 | 83.00 |
| Dec 31, 2023 | -745.00 |
| Sep 30, 2023 | -624.00 |
| Jun 30, 2023 | 543.00 |
| Mar 31, 2023 | 3,754.00 |
| Dec 31, 2022 | 843.00 |
| Sep 30, 2022 | -610.00 |
| Jun 30, 2022 | -343.00 |
| Mar 31, 2022 | -675.00 |
| Dec 31, 2021 | 370.00 |
| Sep 30, 2021 | 881.00 |
| Jun 30, 2021 | -1,249.00 |